31,840 Shares in Genpact Limited $G Acquired by Jackson Creek Investment Advisors LLC

Jackson Creek Investment Advisors LLC bought a new position in shares of Genpact Limited (NYSE:GFree Report) in the fourth quarter, HoldingsChannel reports. The firm bought 31,840 shares of the business services provider’s stock, valued at approximately $1,489,000.

A number of other large investors have also bought and sold shares of G. AQR Capital Management LLC increased its stake in Genpact by 170.4% during the 3rd quarter. AQR Capital Management LLC now owns 3,443,472 shares of the business services provider’s stock worth $144,247,000 after purchasing an additional 2,170,145 shares in the last quarter. Clark Capital Management Group Inc. boosted its position in Genpact by 157.9% during the 3rd quarter. Clark Capital Management Group Inc. now owns 1,864,198 shares of the business services provider’s stock worth $78,091,000 after acquiring an additional 1,141,480 shares during the last quarter. Allianz Asset Management GmbH boosted its position in Genpact by 153.6% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,597,446 shares of the business services provider’s stock worth $66,917,000 after acquiring an additional 967,559 shares during the last quarter. Invesco Ltd. boosted its position in Genpact by 52.9% during the 3rd quarter. Invesco Ltd. now owns 2,145,762 shares of the business services provider’s stock worth $89,886,000 after acquiring an additional 742,470 shares during the last quarter. Finally, UBS Group AG boosted its position in Genpact by 140.5% during the 3rd quarter. UBS Group AG now owns 1,007,358 shares of the business services provider’s stock worth $42,198,000 after acquiring an additional 588,449 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Balkrishan Kalra sold 2,800 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total value of $114,156.00. Following the sale, the chief executive officer owned 525,007 shares in the company, valued at approximately $21,404,535.39. This represents a 0.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.58% of the company’s stock.

Genpact Trading Up 1.2%

Shares of Genpact stock opened at $31.56 on Thursday. Genpact Limited has a 12-month low of $28.78 and a 12-month high of $48.64. The stock has a market cap of $5.35 billion, a P/E ratio of 9.68, a P/E/G ratio of 0.88 and a beta of 0.61. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.47. The business’s 50 day moving average is $34.89 and its 200-day moving average is $40.58.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The business services provider reported $0.98 earnings per share (EPS) for the quarter. Genpact had a return on equity of 22.70% and a net margin of 11.04%.The company had revenue of $1.30 billion for the quarter. Equities research analysts predict that Genpact Limited will post 3.64 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be paid a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Wednesday, June 10th. Genpact’s dividend payout ratio is 23.01%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on G. Robert W. Baird reduced their price target on Genpact from $54.00 to $45.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Wall Street Zen downgraded Genpact from a “buy” rating to a “hold” rating in a research report on Saturday, March 14th. Susquehanna reduced their price target on Genpact from $42.00 to $37.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a research report on Friday, May 8th. Finally, Citigroup reduced their price target on Genpact from $43.00 to $35.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, Genpact presently has a consensus rating of “Hold” and a consensus price target of $43.29.

View Our Latest Report on G

Genpact Profile

(Free Report)

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.